These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38361240)

  • 1. Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia.
    Tan L; Kluivers ACM; Cruz-López EO; Broekhuizen M; Chen Z; Neuman RI; Schoenmakers S; Ruijgrok L; van de Velde D; de Winter BCM; van den Bogaerdt AJ; Lu X; Danser AHJ; Verdonk K
    Hypertension; 2024 Apr; 81(4):861-875. PubMed ID: 38361240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
    Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
    Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ; Yang Z; Huai J; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1).
    Neuman RI; Baars MD; Saleh L; Broekhuizen M; Nieboer D; Cornette J; Schoenmakers S; Verhoeven M; Koch BCP; Russcher H; van den Berg SAA; van den Meiracker AH; Visser W; Danser AHJ
    Hypertension; 2022 Jun; 79(6):1297-1307. PubMed ID: 35341328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
    Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
    Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
    Ren Z; Cui N; Zhu M; Khalil RA
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
    Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
    PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of statins on preeclampsia: A systematic review.
    Vahedian-Azimi A; Karimi L; Reiner Ž; Makvandi S; Sahebkar A
    Pregnancy Hypertens; 2021 Mar; 23():123-130. PubMed ID: 33333432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pravastatin Effects on Placental Prosurvival Molecular Pathways in a Mouse Model of Preeclampsia.
    Saad AF; Diken ZM; Kechichian TB; Clark SM; Olson GL; Saade GR; Costantine MM
    Reprod Sci; 2016 Nov; 23(11):1593-1599. PubMed ID: 27170663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
    Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
    Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model.
    Kumasawa K; Ikawa M; Kidoya H; Hasuwa H; Saito-Fujita T; Morioka Y; Takakura N; Kimura T; Okabe M
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1451-5. PubMed ID: 21187414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women.
    Sovio U; Gaccioli F; Cook E; Hund M; Charnock-Jones DS; Smith GC
    Hypertension; 2017 Apr; 69(4):731-738. PubMed ID: 28167687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of soluble fms-like tyrosine kinase-1 against placental growth factor for preeclampsia in a Chinese pregnant women population.
    Yu F; Bai Q; Zhang S; Jiang Y
    J Clin Lab Anal; 2019 Jun; 33(5):e22861. PubMed ID: 30758082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.
    Gurnadi JI; Mose J; Handono B; Satari MH; Anwar AD; Fauziah PN; Yogi Pramatirta A; Rihibiha DD
    BMC Res Notes; 2015 Oct; 8():534. PubMed ID: 26434493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
    Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
    BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.